BP / Relevant Treatment Discontinuation Information / Peginesatide Group / Target / excretion AE / EPO / Affymax Inc. / Redaction Peginesatide Affymax Inc. / Peginesatide Affymax Inc. / /
Country
United States / /
Currency
pence / /
Event
FDA Phase / /
IndustryTerm
treatment of anemia due to chronic kidney disease / /
New Zealand PD / Temporal Association / Central Intelligence Agency / African Union / FDA Food and Drug Administration / Administration for Mean Change / European Union / NHS / /
Person
Adverse Cardiovascular / /
Position
Hb / Confirmed Hb / EXECUTIVE / Major / General / Explanation Hb / /